Dr. MiltieAtlas by Dr. Miltie™Healthcare Grant Intelligence
Active - staged Solution Summary windowsAtlas Opportunity Score 72/100

HHS ARPA-H SPECTRA Autism Precision Health R&D — ARPA-H-SOL-26-163

FundingNot stated on the public ARPA-H program page. Review the controlling SAM.gov solicitation and attachments for award structure, funding, milestone, and payment terms.
DeadlineTA4 Solution Summary due October 18, 2026 at 5:00 PM ET; TA1 and TA2 Solution Summaries due December 2, 2026 at 5:00 PM ET; TA3 Solution Summary due January 18, 2027 at 5:00 PM ET. Full Proposal deadlines to be announced.
Last verifiedOctober 3, 2026
Required next actionReview ARPA-H-SOL-26-163 and current SAM.gov attachments, select the applicable technical area, confirm proposer eligibility and a specific team contribution, and prepare the required Solution Summary within the applicable submission window. TA4 is due October 18, 2026 at 5:00 PM ET; TA1 and TA2 are due December 2, 2026 at 5:00 PM ET; TA3 is due January 18, 2027 at 5:00 PM ET.

Broad Eligibility

ARPA-H invites cross-disciplinary proposer teams. Exact proposer eligibility, exclusions, registrations, teaming rules, award instrument, and participation requirements are controlled by ARPA-H-SOL-26-163 and its attachments on SAM.gov.

Atlas Analysis

Active opportunity. Review the current ARPA-H SPECTRA solicitation and SAM.gov attachments for scope, eligibility, technical requirements, and submission instructions.

The HHS Advanced Research Projects Agency for Health (ARPA-H) has opened the Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) Innovative Solutions Opening, Notice ID ARPA-H-SOL-26-163. SPECTRA is a major autism precision-health research program intended to combine biological, clinical, developmental, environmental, family, behavioral, and real-world data to improve assessment, understand individual trajectories, and enable more individualized interventions and supports across the lifespan.

ARPA-H is seeking cross-disciplinary solutions across four technical areas: TA1 Analysis, covering tools that characterize genetic, environmental, family, metabolic, immune, and developmental factors; TA2 Modeling, focused on federated and privacy-preserving AI platforms; TA3 Precision Intervention, focused on individualized selection and rigorous testing of interventions; and TA4 Enabling Technologies, focused on accessible communication, quality-of-life, and embedded-assessment tools that measure real-world function through ordinary use.

A required Solution Summary is the entry gate and the schedule varies by technical area. TA4 Solution Summaries are due October 18, 2026 at 5:00 PM ET, with submissions opening October 4. TA1 and TA2 Solution Summaries are due December 2, 2026 at 5:00 PM ET, with submissions opening November 18. TA3 Solution Summaries are due January 18, 2027 at 5:00 PM ET, with submissions opening January 4, 2027. Full-proposal deadlines are to be announced. Submission is through the ARPA-H Solutions portal, while the controlling solicitation, eligibility terms, evaluation criteria, templates, registrations, award structure, and any amendments are maintained on SAM.gov under ARPA-H-SOL-26-163.

Atlas Opportunity Score: 72/100. N9+ Fit: 38/100. SPECTRA is highly relevant to digital health, embedded assessment, real-world measurement, and precision-care technology, especially TA4, but Dr. Miltie should not be advanced as a prime or named technical contributor unless a specific qualifying capability and performance basis can be documented for the proposed technical area.

Source verificationOfficial government source · arpa-h.govAtlas last verified this record October 3, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗